MDNC / Medinotec Inc. - SEC फाइलिंग, वार्षिक रिपोर्ट, प्रॉक्सी स्टेटमेंट

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☒ Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended May 31, 2025 ☐ Transition Report pursuant to 13 o

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☒ Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended May 31, 2025 or ☐ Transition Report pursuant to 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File Number: 000-56737 Medinotec Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SEC FILE NUMBER 333-265368 NOTIFICATION OF LATE FILING (Check One): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: May 31, 2025 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q ☐ Transitio

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended February 28, 2025 ☐ TRANSITION REPORT PURSUA

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended February 28, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-56737 MEDINOTEC, INC

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 Medinotec, Inc. (Exact name of registrant as sp

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 Medinotec, Inc.

Regulation FD Disclosure, Financial Statements and Exhibits

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 20, 2025 Medinotec, Inc. (Exact name of registrant as specified in its charter) Nevada 333-265368 36-4990343 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S.

Notice of 2024 Annual Meeting of Stockholders Date and Time YOUR VOTE IS IMPORTANT Tuesday, February 19, 2025 at 9:30 a.m. (EST) Wether or not you attend the annual meeting, we urge you to vote promptly no later than the day before the meeting by: Me

Notice of 2024 Annual Meeting of Stockholders Date and Time YOUR VOTE IS IMPORTANT Tuesday, February 19, 2025 at 9:30 a.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☒ Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended November 30, 2024 ☐ Transition Report pursuant to

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☒ Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended November 30, 2024 or ☐ Transition Report pursuant to 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File Number: 333-265368 Medinotec Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☒ Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended August 31, 2024 ☐ Transition Report pursuant to 1

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☒ Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended August 31, 2024 or ☐ Transition Report pursuant to 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File Number: 333-265368 Medinotec Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☒ Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended May 31, 2024 ☐ Transition Report pursuant to 13 o

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☒ Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended May 31, 2024 or ☐ Transition Report pursuant to 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File Number: 333-265368 Medinotec, Inc.

Letter from BDO South Africa Inc. to the Securities and Exchange Commission

Tel: +27 011 488 1700 Fax: +27 011 488 1701 www.bdo.co.za Wanderers Office Park 52 Corlett Drive Illovo, 2196 Private Bag X60500 Houghton, 2041 South Africs July 8, 2024 Securities and Exchange Commission 100 F Street N.E. Washington, D.C. 20549 We have been furnished with a copy of the response to Item 4.01 of Form 8-K for the event that occurred on July 8, 2024, to be filed by our former client,

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ____________________ FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 8, 2024 Medinotec, In

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 8, 2024 Medinotec, Inc. (Exact name of registrant as specified in its charter) Nevada 333-265368 36-4990343 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Empl

Description of Registrant’s Securities

DESCRIPTION OF SECURITIES Our authorized capital stock consists of 200,000,000 shares of common stock, with a par value of $0.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended February 29, 2024 ☐ TRANSITION REPORT PURSUA

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended February 29, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 333-265368 MEDINOTEC, IN

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SEC FILE NUMBER 333-265368 NOTIFICATION OF LATE FILING (Check One): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: February 29, 2024 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q ☐ Tran

Submission of Matters to a Vote of Security Holders

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 19, 2024 Medinotec, Inc. (Exact name of registrant as specified in its charter) Nevada 333-265368 36-4990343 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Em

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☒ Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended November 30, 2023 ☐ Transition Report pursuant to

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☒ Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended November 30, 2023 or ☐ Transition Report pursuant to 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File Number: 333-265368 Medinotec, Inc.

Notice of 2023 Annual Meeting of Stockholders Date and Time YOUR VOTE IS IMPORTANT Tuesday,March 19, 2024 at 10:00 a.m. (EDT) Wether or not you attend the annual meeting, we urge you to vote promptly no later than the day before the meeting by: Meeti

Notice of 2023 Annual Meeting of Stockholders Date and Time YOUR VOTE IS IMPORTANT Tuesday,March 19, 2024 at 10:00 a.

Regulation FD Disclosure, Financial Statements and Exhibits

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 22, 2024 Medinotec, Inc. (Exact name of registrant as specified in its charter) Nevada 333-265368 36-4990343 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SEC FILE NUMBER 333-265368 NOTIFICATION OF LATE FILING (Check One): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: November 30, 2023 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q ☐ Tran

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☒ Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended August 31, 2023 ☐ Transition Report pursuant to 1

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☒ Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended August 31, 2023 or ☐ Transition Report pursuant to 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File Number: 333-265368 Medinotec, Inc.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 11, 2023 Medinotec Inc. (Exact name of registrant as specified in its charter) Nevada 333-265368 36-4990343 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. E

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☒ Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended May 31, 2023 ☐ Transition Report pursuant to 13 o

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☒ Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended May 31, 2023 or ☐ Transition Report pursuant to 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File Number: 333-265368 Medinotec, Inc.

Letter from Mercurius & Associates LLP (formerly known as AJSH & Co LLP) to the Securities and Exchange Commission

Mercurius & Associates LLP A-94/8, Wazirpur Industrial Area, Main Ring Road, Delhi – 110052 +91 11 45596689 www.

MEDINOTEC, INC. AUDIT COMMITTEE CHARTER

EX-99.1 6 ex991.htm MEDINOTEC, INC. AUDIT COMMITTEE CHARTER CONTENTS 1. EXECUTIVE SUMMARY 2 2. PURPOSE, COMPOSITION AND MEETINGS OF THE COMMITTEE 2 3. DUTIES, POWERS AND RESPONSIBILITIES 4 4. RESOURCES AND AUTHORITY 17 5. REVISION 17 2 1. EXECUTIVE SUMMARY 1.1. Medinotec, Inc. (the “Company”) has duly constituted an Audit Committee (the “Committee”) of the Board of Directors (the “Board”). The Com

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ____________________ FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 20, 2023 Medinotec In

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 20, 2023 Medinotec Inc. (Exact name of registrant as specified in its charter) Nevada 333-265368 36-4990343 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Empl

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended February 28, 2023 ☐ TRANSITION REPORT PURSUA

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended February 28, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number: 333-265368 MEDINOTEC,

List of Subsidiaries Medinotec Capital Proprietary Limited and DISA Medinotec Proprietary Limited

List of Subsidiaries DISA Medinotec Proprietary Limited (South Africa) Medinotec Capital Proprietary Limited (South Africa)

Medinotec CFO Pieter van Niekerk joined Natalie Stoberman from the Proactive studio to discuss how the company's reach in niche medical device manufacturing and distribution is growing in North America.

Medinotec CFO Pieter van Niekerk joined Natalie Stoberman from the Proactive studio to discuss how the company's reach in niche medical device manufacturing and distribution is growing in North America.

Regulation FD Disclosure, Financial Statements and Exhibits

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 17, 2023 Medinotec Inc. (Exact name of registrant as specified in its charter) Nevada 333-265368 36-4990343 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Emplo

Regulation FD Disclosure, Financial Statements and Exhibits

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 31, 2023 Medinotec Inc. (Exact name of registrant as specified in its charter) Nevada 333-265368 36-4990343 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Emp

OTC Markets Group Welcomes Medinotec Inc. to OTCQX

OTC Markets Group Welcomes Medinotec Inc. to OTCQX Press Release | 03/31/2023 NEW YORK, March 31, 2023 (GLOBE NEWSWIRE) - OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for 12,000 U.S. and international securities, today announced Medinotec Inc. (OTCQX: MDNC), a US-based company with a primary investment in DISA Medinotec, has qualified to trade on the OTCQX® Best Market. Medi

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ____________________ FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 21, 2023 Medinotec I

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 21, 2023 Medinotec Inc. (Exact name of registrant as specified in its charter) Nevada 333-265368 36-4990343 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Emp

MEDINOTEC, INC. ANNOUNCES Assignment of an Over-the-Counter Quoting and Trading Symbol (MDNC) for the Common Stock of Medinotec Inc.

MEDINOTEC, INC. ANNOUNCES Assignment of an Over-the-Counter Quoting and Trading Symbol (MDNC) for the Common Stock of Medinotec Inc. Las Vegas, NV – March 21, 2023 - Medinotec, Inc. (the “Company”) (OTCPink: MDNC), a US-based company with a primary investment in DISA Medinotec, a South African medical device manufacturing and distribution company, in managements opinion a global leader in tracheal

Other Events

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 10, 2023 Medinotec Inc. (Exact name of registrant as specified in its charter) Nevada 333-265368 36-4990343 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Emp

Report of Independent Registered Public Accounting Firm

EX-99.1 2 ex991.htm Mercurius & Associates LLP A-94/8, Wazirpur Industrial Area, Main Ring Road, Delhi – 110052 +91 11 45596689 www.ajsh.in [email protected] (Formerly known as AJSH & Co LLP) LPIN: AAG-1471 Report of Independent Registered Public Accounting Firm To the Shareholders and Board of Directors of Medinotec Inc. Opinion on the Financial Statements We have audited the accompanying Consolidated

Financial Statements and Exhibits, Results of Operations and Financial Condition

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 8, 2023 Medinotec Inc. (Exact name of registrant as specified in its charter) Nevada 333-265368 36-4990343 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. E

MEDINOTEC –Progress Made Towards Quotation On The OTCQX Markets

EX-99.1 2 ex991.htm MEDINOTEC –Progress Made Towards Quotation On The OTCQX Markets Las Vegas, NV, January 19, 2023 - Medinotec, Inc. today published a shareholder update from CFO Pieter van Niekerk. The update highlights the company’s cash reserves that is insulating it from the prevailing bear market. This providing Medinotec Inc Group with the necessary resources it needs to continue its path t

Financial Statements and Exhibits, Results of Operations and Financial Condition

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 19, 2023 Medinotec, Inc. (Exact name of registrant as specified in its charter) Nevada 333-265368 36-4990343 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☒ Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended November 30, 2022 ☐ Transition Report pursuant to

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☒ Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended November 30, 2022 or ☐ Transition Report pursuant to 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File Number: 333-265368 Medinotec, Inc.

MEDINOTEC, INC.

MEDINOTEC, INC. November 29, 2022 THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION Attn: Abby Adams Division of Corporation Finance Mail Stop 7010 100 F. Street NE Washington, D.C. 20549-7010 Re: Medinotec Inc. Registration Statement on Form S-1, as amended Originally Filed June 2, 2022 File No. 333-265368 Dear Ms. Gorman: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Medi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1/A Amendment No. 5 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MEDINOTEC INC. (Exact name of registrant as specified in its charter)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1/A Amendment No. 5 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MEDINOTEC INC. (Exact name of registrant as specified in its charter) Nevada 3841 36-4990343 (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1/A Amendment No. 4 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MEDINOTEC INC. (Exact name of registrant as specified in its charter)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1/A Amendment No. 4 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MEDINOTEC INC. (Exact name of registrant as specified in its charter) Nevada 3841 36-4990343 (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification

Unsecured Revolving Promissory Note, dated September 16, 2022

EX-4.1 21 ex41.htm UNSECURED REVOLVING PROMISSORY NOTE Up to $750,000 September 16, 2022 FOR VALUE RECEIVED, the undersigned, INNOVATIVE OUTCOMES INC, an Arkansas corporation ("Borrower"), having an address at 7003 Valley Ranch Drive, Little Rock, Arkansas 72223, promises to pay to the order of MEDINOTEC, INC. ("Lender"), having an address at 200 Broad Hollow Road, Suite 207, Melville, NY 11747, t

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1/A Amendment No. 3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MEDINOTEC INC. (Exact name of registrant as specified in its charter)

S-1/A 1 medinotecs1a.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1/A Amendment No. 3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MEDINOTEC INC. (Exact name of registrant as specified in its charter) Nevada 3841 36-4990343 (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) (I.R.S.

Letter from De Vos Richards Abed, dated August 23, 2022(3)

23/08/2022 To whom it may concern; Confirmation Letter Disa Medinotec Proprietary Limited Registration number: 2015/115015/07 We, De Vos Richards Abed, hereby confirm that we were the former principal accountants of Disa Medinotec Proprietary Limited, Registration number: 2015/115015/07 We resigned in our capacity as auditors due to our firm not being registered with the PCAOB on the 12th of March 2021.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1/A Amendment No. 2 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MEDINOTEC INC. (Exact name of registrant as specified in its charter)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1/A Amendment No. 2 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MEDINOTEC INC. (Exact name of registrant as specified in its charter) Nevada 3841 36-4990343 (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification

Letter of Offer, dated April 26, 2021 with Gregory Vizirgianakis

April 26, 2021 Attention: Mr G Vizirgianakis Letter of Offer We the above-mentioned company Medinotec Incorporated, would like to make the following offer as discussed.

Letter of Offer, dated April 26, 2021 with Peter van Niekerk

April 26, 2021 Attention: Mr PM van Niekerk Letter of Offer We the above-mentioned company Medinotec Incorporated, would like to make the following offer as discussed.

Letter of Offer, dated June 13, 2021 with Joseph P Dwyer

June 13, 2022 Attention: Mr J Dwyer Letter of Offer We the above-mentioned company Medinotec Incorporated, would like to make the following offer as discussed.

Letter of Offer, dated June 13, 2021 with Stavros Vizirgianakis

EX-10.5 23 ex105.htm June 13, 2022 Attention: Mr S Vizirgianakis Letter of Offer We the above-mentioned company Medinotec Incorporated, would like to make the following offer as discussed. 1. Basic Remuneration Package of $0 per year. The package and the term of service will be subject to change upon review by the remuneration committee once a bench marking report have been created and the committ

Loan Certificate dated Mary 1, 2017

EX-10.7 25 ex107.htm LOAN CERTIFICATE INFORMATION SUPPLIED BY MINOAN MEDICAL PROPRIETARY LIMITED MINOAN MEDICAL PROPRIETARY LIMITED I hereby certify that there is a loan facility in place between Minoan Medical and DISA Medinotec, the loan can be drawn down to a maximum of $2.5 Million and carries the following terms and conditions Security held: UNSECURED Interest rate: SOUTH AFRICA PRIME RATE% R

CALCULATION OF REGISTRATION FEE

EX-FILING FEES 32 ex107.htm CALCULATION OF REGISTRATION FEE Title of each class of securities to be registered Amount to be Registered(1) Proposed Maximum Offering Price per Share(3) Proposed Maximum Aggregate Offering Price(3) Amount of Registration Fee Common Stock, par value $0.001 per share 1,733,750 (2) $5.00 $8,668,750 $803.59 (1) Pursuant to Rule 416 under the Securities Act of 1933, as ame

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1/A Amendment No. 1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MEDINOTEC INC. (Exact name of registrant as specified in its charter)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1/A Amendment No. 1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MEDINOTEC INC. (Exact name of registrant as specified in its charter) Nevada 3841 36-4990343 (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification

CALCULATION OF REGISTRATION FEE

EX-FILING FEES 26 ex107.htm CALCULATION OF REGISTRATION FEE Title of each class of securities to be registered Amount to be Registered(1) Proposed Maximum Offering Price per Share(3) Proposed Maximum Aggregate Offering Price(3) Amount of Registration Fee Common Stock, par value $0.001 per share 1,733,750 (2) $5.00 $8,668,750 $803.59 (1) Pursuant to Rule 416 under the Securities Act of 1933, as ame

Lease Agreement dated January 28, 2020 between Minoan Capital and DISA Medinotec Proprietary Limited

Capital AGREEMENT OF LEASE THE SCHEDULE 1 THE LANDLORD Name: MINOAN CAPITAL PTY LTD Registration No.

Exclusive Distribution Agreement dated March 1, 2020 between Disa Life Sciences Proprietary Limited and DISA Medinotec Proprietary Limited

DISA MEDINOTEC DISA Medinotec (Pty) Ltd T: +27 (0)87 330 2301 Stand 171, Northlands Business Park Bush Telegraph Street F: +27(0)86 441 5089 Northriding, Gauteng 2169 South Africa www.

Share Exchange Agreement, dated March 2, 2022(1)

SALE OF SHARES AGREEMENT, DATED 2 MARCH, 2022 SALE OF SHARES AGREEMENT entered into between Minoan Medical Proprietary Limited, (Registration Number 2015/055306/07) (“the Seller”) and MEDINOTEC CAPITAL PROPRIETARY LIMITED, (Registration Number: 2021/000610/07) (“the Purchaser”) and DISA MEDINOTEC PROPRIETARY LIMITED, (Registration Number: 2015 / 115015 / 07) (“the Company”) TABLE OF CONTENTS 1.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MEDINOTEC INC. (Exact name of registrant as specified in its charter)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MEDINOTEC INC. (Exact name of registrant as specified in its charter) Nevada 3841 36-4990343 (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification No.) 10120 W Flami

CALCULATION OF REGISTRATION FEE

EX-FILING FEES 8 ex107.htm CALCULATION OF REGISTRATION FEE Title of each class of securities to be registered Amount to be Registered(1) Proposed Maximum Offering Price per Share(3) Proposed Maximum Aggregate Offering Price(3) Amount of Registration Fee Common Stock, par value $0.001 per share 1,733,750 (2) $5.00 $8,668,750 $803.59 (1) Pursuant to Rule 416 under the Securities Act of 1933, as amen

Bylaws of the Company(1)

BY-LAWS OF MINOAN MEDICAL INC. (A NEVADA CORPORATION) ARTICLE I OFFICES Section 1. Registered Office. The registered office of the corporation in the State of Nevada shall be at such place as the board shall resolve. Section 2. Other Offices. The corporation shall also have and maintain an office or principal place of business at such place as may be fixed by the Board of Directors, and may also h

Articles of Amendment

BARBARA K. CEGAVSKE Secretary of State 202 North Carson Street Carson City, Nevada 89701-4201 (775) 684-5708 Website: www.nvsos.gov www.nvsilverflume.gov Filed in the Office of Secretary of State State Of Nevada Business Number E14093812021-5 Filing Number 20211824938 Filed On 10/15/2021 10:35:55 AM Number of Pages 3 TYPE OR PRINT - USE DARK INK ONLY - DO NOT HIGHLIGHT 1. Entity information Name o

Articles of Incorporation of Medinotec Inc.

BARBARA K. CEGAVSKE Secretary of State 202 North Carson Street Carson City, Nevada 89701-4201 (775) 684-5708 Website: www.nvsos.gov www.nvsilverflume.gov TYPE OR PRINT - USE DARK INK ONLY - DO NOT HIGH LIGHT 1. Name of Entity: (If foreign, name in home jurisdiction) Minoan Medical Inc. 2. Registered Agent for Service of Process: (Check only one box) Commercial Registered Noncommercial Registered A